Contact me
A qualified lawyer and nurse and longstanding member of an NHS Research Ethics Committee, Alison leads PHG Foundation’s regulation and ethics team. Recent work includes advocacy on data and device regulation that impacts innovations in healthcare. This includes appraising the impact of regulatory changes to EU data protection and medical devices regulation for clinical genetics services and medical research; working with stakeholders and statutory authorities to facilitate optimal data sharing policies in the NHS; and assessing how existing and future in vitro diagnostic devices regulation might impact on IVD device and software development.
Alison Hall
- Reports
- The ethical and legal framework for a Genomics England and Sano Genetics participant engagement platform
- Polygenic scores and clinical utility
- Visual identifiers in the care of people with dementia
- Citizen generated data and health: predictive-prevention
- The GDPR and genomic data
- Black box medicine and transparency
- Person centred healthcare
- Overdiagnosis
- Privacy and autonomy
- Algorithms as medical devices
- Regulating algorithms in healthcare: the GDPR and IVDR in practice
- Polygenic scores, risk and cardiovascular disease
- Genomics in mainstream clinical pathways
- Identification and genomic data
- Personalised prevention in breast cancer – the policy landscape
- Variant classification and interpretation - workshop report
- Data sharing to support UK clinical genetics and genomics services
- Pathogen genomics into practice
- Realising Genomics in Clinical Practice
- Stratified Screening for Cancer
- Realising Genomics in Clinical Practice (interim report)
- Managing incidental and pertinent findings from WGS in the 100,000 Genomes Project
- Next steps in the sequence
- Public health in an era of genome-based and personalised medicine
- Independent response to House of Lords Science and Technology Committee Genomic Medicine report
- Assessment of the Human Tissue Act
- Policy briefings
- Somatic genome editing: ethics and regulation
- Somatic genome editing: an overview
- Citizen generated data: the ethics of remote patient monitoring
- Legal Liability for machine learning in healthcare
- What is the IVDR?
- Sharing clinical genomic data for better diagnostics
- The impact of genomic sequencing technologies on patient pathways
- Genomics and the boundary between research and clinical care and treatment
- ELSI* and the implemention of WGS / WES in clinical practice
- Discussion papers
- Impact of Schrems II on genomic data sharing
- Why explainable machine learning matters for health
- A right to explanation?
- Blogs
- Moving forward the debate on AI regulation
- Identification and genomic data
- How should UK healthcare prepare for reforms to the EU data protection?
- Review of data security, consent and opt-outs
- Complex diseases need complex solutions – including genomics
- Updated international guidance on human genome and human rights
- Impact of In Vitro Diagnostic Devices regulatory reforms on genetic testing
- Realising Genomics in Clinical Practice - a framework for action
- US clarifies position on secondary findings in clinical genome sequencing
- The impact of genomic sequencing technologies on patient pathways
- AAP guidelines on genetic testing of children: a commentary
- Where are the boundaries for ethical population health policy?
- Do patients have a right to access their clinical sequence data?
- Proposed EU Data Protection reform and public health genomics
- Publications
Genetic database software as medical devices
Thorogood A, Touré S.B, Ordish J, Hall A, Knoppers B.
Human Mutation. 2018; Vol. 39 Iss.11. pp1702-1712.
-
Samuel, G, Howard H.C, Cornel M, van El C, Hall A, Forzano F, Prainsack B.
Forensic Science International. 2018 5 July; Genetics (online).
Risk stratification, genomic data and the law
Hall A, Finnegan T, Susmita C et al.
J Community Genet. 2018;9:195.
-
Murtagh M, B Mwenza, H Alison et al.
Hum Genomics. 2018;12:24
Risk stratification, genomic data and the law.
Hall A, Finnegan T, Chowdhury S, Dent T, Kroese M, Burton H.
J Community Genet. 2018; https://doi.org/10.1007/s12687-018-0358-4. [Epub ahead of print]
Genomic medicine and data sharing
Raza S, Hall A.
Br Med Bull. 2017 Sep; 1;123(1):35-45.
Exploring the potential duty of care in clinical genomics under UK law
Mitchell C, Ploem C, Chico V, Ormondroyd E, Hall A, Wallace S, Fay M, Goodwin D, Bell J, Phillips S, Taylor J.C, Hennekam R, Kaye J.
Medical Law International. 2017 Aug 14 [Epub ahead of print]
-
Chowdhury S, Hall A, Pashayan N, Pharoah P.
Journal of Medical Ethics. 2013 Mar 1 [Epub ahead of print] PubMed PMID: 23454719
-
Bewshea C, Carrieri D, Hall A, Walker G.
J Med Ethics doi:10.1136/medethics-2016-103530
Responsible implementation of expanded carrier screening
Henneman L, Borry P, Hall A.
Eur J Hum Genet. 2016 Jun; 24(6)w1-e12.
Known unknowns: building an ethics of uncertainty into genomic medicine
Gaff C, Hall A, Leonard S, Newson A.
BMC Medical Genomics (2016) 9:57 DOI 10.1186/s12920-016-0219-0
-
de Wert G, Dondorp W, Hall A.
European Journal of Human Genetics. 2015 March 18.
-
Bowman E, Goldring K, Gveric D, Hall A, Lacerda E, Nacul L, O'Donovan D, Pheby D.
BMC Research Notes. 2014; (7):370.
Personalized medicine: what's in a name?
Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G, Stewart A.
Personalised Medicine. 2014; 11(2):197-210.
-
Alberg C, Hall A, Hallowell N, Zimmern R.
Journal of Medical Ethics. Epub 2014 Jul 18.
-
Nacul L,Stewart A, Alberg C, Chowdhury S, Burton H, Darlison MW, Grollman C, Hall A, Modell B, Moorthie S, Sagoo G, .
Journal of Public Health. 2014 June; 36(2):243-50. doi: 10.1093/pubmed/fdt048 : May 10, 2013 [Epub ahead of print]
Personalised medicine in the UK: challenges of implementation and impact on healthcare system
Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G.
Genome Medicine. 2014 Apr 25; 6(4):28.
-
Burton H, Chowdhury S, Hall A, Pashayan N, Pharoah P.
Journal of Medical Ethics. 2014 Mar; 40(3):163-7.
Public health genomics and personalised prevention: lessons from the COGS project
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Journal of Internal Medicine. 2013 Nov; 274(5):451-6
Life insurance: genomic stratification and risk classification
Burton H, Chowdhury S, Dent T, Feze I, Foulkes W, Hall A, Hamet P, Joly Y, Kirwan N, Knoppers B, Macdonald A, Pashayan N, Simard J, Van Hoyweghen I.
European Journal of Human Genetics. 2013 Oct 16. doi: 10.1038/ejhg.2013.228
-
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Journal of Public Health (Oxf). 2013 Aug 28.
Public health implications from COGS and potential for risk stratification and screening
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Nature Genetics. 2013 Apr; 45(4):349-51 doi: 10.1038/ng.2582. PubMed PMID: 23535723
Informatics and clinical genome sequencing: opening the black box
Moorthie S, Hall A, Wright C.
Genet Medicine. 2013 Mar; 15(3):165-71.
Incorporating genomics into breast and prostate cancer screening: assessing the implications
Burton H, Chowdhury S, Dent T, Hall A, Hall P, Lyratzopoulos G, Pashayan N, Pharoah P.
Genetics in Medicine. 2013 Feb 14 doi: 10.1038/gim.2012.167. [Epub ahead of print] PubMed PMID: 23412607.
Stratified cancer screening: the practicalities of implementation.
Burton H, Chowdhury S, Dent T, Eccles D, Eeles R, Hall A, Jbilou J, Lyratzopoulos G, Pashayan N, Pharoah P, Rafi I, Segnan N, T.
Public Health Genomics. 2013;16(3):94-9.
Legal and ethical implications of inherited cardiac disease in clinical practice within the UK
Journal of Medical Ethics. 2010; 36: 762-766.
-
Burke W, Hall A, Karmali M, Khoury M, Knoppers B, Meslin E, Stanley F, Wright C, Zimmern R.
Genetics in Medicine. 2010 Nov; Vol 15.
Regulating direct-to-consumer genetic tests: What is all the fuss about?
Genetics in Medicine. 2010 Oct 1 [Epub ahead of print]
Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications
Bostanci A, Hall A, Wright C.
Public Health Genomics. 2010; 13(4):246-55. Epub 2010 Apr 15.
Inherited cardiovascular conditions: the challenges of genomic medicine
Alberg C, Burton H, Hall A, Inherited Cardiovascular Conditions Services , Sagoo G, Stewart A.
Heart. 2010 Mar; 96(6):474-6
Biomarkers, Dementia, and Public Health
Brayne C, Hall A, Matthews F, Wright C.
Annals of the New York Academy of Sciences. 2009; 118:11-19.
Beyond Bristol and Alder Hey: The Future Regulation of Human Tissue
Hall A, Liddell K.
Medical Law Review. 2005; Summer:170-223